PRF Technologies (PRFX) Research & Development (2020 - 2024)
PRF Technologies' (PRFX) quarterly Research & Development came in at -$16.1 million in Q2 2024, down 488.76% YoY from $4.2 million in Q3 2023, and down 440.55% on a QoQ basis from $4.7 million in Q1 2024.
PRF Technologies (PRFX) Research & Development (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has 5 years of Research & Development data on file, last reported at -$16.1 million in Q2 2024.
- Quarterly Research & Development fell 488.76% year-over-year to -$16.1 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$8.1 million (down 241.64% YoY) and the FY2025 annual result came in at $1.1 million, down 90.29% from the prior year.
- Research & Development fell to -$16.1 million in Q2 2024, from $4.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $9.3 million in Q4 2023 to a low of -$16.1 million in Q2 2024.
- A 5-year average of $125777.8 and a median of $564500.0 in 2021 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 3001.12% in 2021, down 4187.5% in 2021.
- Tracing PRFX's Research & Development over 5 years: stood at $446000.0 in 2020, then advanced by 24.66% to $556000.0 in 2021, then surged by 250.54% to $1.9 million in 2022, then soared by 378.4% to $9.3 million in 2023, then tumbled by 273.2% to -$16.1 million in 2024.
- The last three Research & Development figures came in at -$16.1 million (Q2 2024), $4.7 million (Q1 2024), and $9.3 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -16.15 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 9.32 Mn |
| Sep 30, 2023 | -5.99 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | -1.45 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 743,000.00 |
| Mar 31, 2022 | 680,000.00 |
| Dec 31, 2021 | 556,000.00 |
| Sep 30, 2021 | 573,000.00 |
| Jun 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | -1.03 Mn |
| Dec 31, 2020 | 446,000.00 |
| Sep 30, 2020 | -157,000.00 |
| Jun 30, 2020 | 89,000.00 |
| Mar 31, 2020 | -24,000.00 |